Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells

Toru Matsu-Ura, Hiroshi Sasaki, Motoi Okada, Katsuhiko Mikoshiba, Muhammad Ashraf

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Pluripotent stem cells, such as embryonic stem cells or induced pluripotent stem cells, have a great potential for regenerative medicine. Induced pluripotent stem cells, in particular, are suitable for replacement of tissue by autologous transplantation. However, tumorigenicity is a major risk in clinical application of both embryonic stem cells and induced pluripotent stem cells. This study explores the possibility of manipulating the cell cycle for inhibition of tumorigenicity. Methods: We genetically modified mouse induced pluripotent stem cells (miPSCs) to overexpress p27 tumor suppressor and examined their proliferation rate, gene expression, cardiac differentiation, tumorigenicity, and therapeutic potential in a mouse model of coronary artery ligation. Results: Overexpression of p27 inhibited cell division of miPSCs, and that inhibition was dependent on the expression level of p27. p27 overexpressing miPSCs had pluripotency characteristics but lost stemness earlier than normal miPSCs during embryoid body and teratoma formation. These cellular characteristics led to none or smaller teratoma when the cells were injected into nude mice. Transplantation of both miPSCs and p27 overexpressing miPSCs into the infarcted mouse heart reduced the infarction size and improved left ventricular function. Conclusions: The overexpression of p27 attenuated tumorigenicity by reducing proliferation and earlier loss of stemness of miPSCs. The overexpression of p27 did not affect pluripotency and differentiation characteristics of miPSC. Therefore, regulation of the proliferation rate of miPSCs offers great therapeutic potential for repair of the injured myocardium.

Original languageEnglish (US)
Article number286
JournalStem Cell Research and Therapy
Volume7
Issue number1
DOIs
StatePublished - Feb 15 2016
Externally publishedYes

Fingerprint

Induced Pluripotent Stem Cells
Teratoma
Stem cells
Embryonic Stem Cells
Embryoid Bodies
Tissue Transplantation
Pluripotent Stem Cells
Regenerative Medicine
Cells
Autologous Transplantation
Left Ventricular Function
Nude Mice
Cell Division
Infarction
Ligation
Coronary Vessels
Myocardium
Cell Cycle
Gene expression
Transplantation

Keywords

  • Cell cycle
  • ES
  • Embryonic stem cell
  • Induced pluripotent stem cell
  • Infarcted heart
  • Stem cell
  • Tumor
  • cdk
  • iPS
  • p27

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Cell Biology

Cite this

Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells. / Matsu-Ura, Toru; Sasaki, Hiroshi; Okada, Motoi; Mikoshiba, Katsuhiko; Ashraf, Muhammad.

In: Stem Cell Research and Therapy, Vol. 7, No. 1, 286, 15.02.2016.

Research output: Contribution to journalArticle

Matsu-Ura, Toru ; Sasaki, Hiroshi ; Okada, Motoi ; Mikoshiba, Katsuhiko ; Ashraf, Muhammad. / Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells. In: Stem Cell Research and Therapy. 2016 ; Vol. 7, No. 1.
@article{7729aa65db0f4d9591ea6ee2049f94cf,
title = "Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells",
abstract = "Background: Pluripotent stem cells, such as embryonic stem cells or induced pluripotent stem cells, have a great potential for regenerative medicine. Induced pluripotent stem cells, in particular, are suitable for replacement of tissue by autologous transplantation. However, tumorigenicity is a major risk in clinical application of both embryonic stem cells and induced pluripotent stem cells. This study explores the possibility of manipulating the cell cycle for inhibition of tumorigenicity. Methods: We genetically modified mouse induced pluripotent stem cells (miPSCs) to overexpress p27 tumor suppressor and examined their proliferation rate, gene expression, cardiac differentiation, tumorigenicity, and therapeutic potential in a mouse model of coronary artery ligation. Results: Overexpression of p27 inhibited cell division of miPSCs, and that inhibition was dependent on the expression level of p27. p27 overexpressing miPSCs had pluripotency characteristics but lost stemness earlier than normal miPSCs during embryoid body and teratoma formation. These cellular characteristics led to none or smaller teratoma when the cells were injected into nude mice. Transplantation of both miPSCs and p27 overexpressing miPSCs into the infarcted mouse heart reduced the infarction size and improved left ventricular function. Conclusions: The overexpression of p27 attenuated tumorigenicity by reducing proliferation and earlier loss of stemness of miPSCs. The overexpression of p27 did not affect pluripotency and differentiation characteristics of miPSC. Therefore, regulation of the proliferation rate of miPSCs offers great therapeutic potential for repair of the injured myocardium.",
keywords = "Cell cycle, ES, Embryonic stem cell, Induced pluripotent stem cell, Infarcted heart, Stem cell, Tumor, cdk, iPS, p27",
author = "Toru Matsu-Ura and Hiroshi Sasaki and Motoi Okada and Katsuhiko Mikoshiba and Muhammad Ashraf",
year = "2016",
month = "2",
day = "15",
doi = "10.1186/s13287-016-0286-3",
language = "English (US)",
volume = "7",
journal = "Stem Cell Research and Therapy",
issn = "1757-6512",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells

AU - Matsu-Ura, Toru

AU - Sasaki, Hiroshi

AU - Okada, Motoi

AU - Mikoshiba, Katsuhiko

AU - Ashraf, Muhammad

PY - 2016/2/15

Y1 - 2016/2/15

N2 - Background: Pluripotent stem cells, such as embryonic stem cells or induced pluripotent stem cells, have a great potential for regenerative medicine. Induced pluripotent stem cells, in particular, are suitable for replacement of tissue by autologous transplantation. However, tumorigenicity is a major risk in clinical application of both embryonic stem cells and induced pluripotent stem cells. This study explores the possibility of manipulating the cell cycle for inhibition of tumorigenicity. Methods: We genetically modified mouse induced pluripotent stem cells (miPSCs) to overexpress p27 tumor suppressor and examined their proliferation rate, gene expression, cardiac differentiation, tumorigenicity, and therapeutic potential in a mouse model of coronary artery ligation. Results: Overexpression of p27 inhibited cell division of miPSCs, and that inhibition was dependent on the expression level of p27. p27 overexpressing miPSCs had pluripotency characteristics but lost stemness earlier than normal miPSCs during embryoid body and teratoma formation. These cellular characteristics led to none or smaller teratoma when the cells were injected into nude mice. Transplantation of both miPSCs and p27 overexpressing miPSCs into the infarcted mouse heart reduced the infarction size and improved left ventricular function. Conclusions: The overexpression of p27 attenuated tumorigenicity by reducing proliferation and earlier loss of stemness of miPSCs. The overexpression of p27 did not affect pluripotency and differentiation characteristics of miPSC. Therefore, regulation of the proliferation rate of miPSCs offers great therapeutic potential for repair of the injured myocardium.

AB - Background: Pluripotent stem cells, such as embryonic stem cells or induced pluripotent stem cells, have a great potential for regenerative medicine. Induced pluripotent stem cells, in particular, are suitable for replacement of tissue by autologous transplantation. However, tumorigenicity is a major risk in clinical application of both embryonic stem cells and induced pluripotent stem cells. This study explores the possibility of manipulating the cell cycle for inhibition of tumorigenicity. Methods: We genetically modified mouse induced pluripotent stem cells (miPSCs) to overexpress p27 tumor suppressor and examined their proliferation rate, gene expression, cardiac differentiation, tumorigenicity, and therapeutic potential in a mouse model of coronary artery ligation. Results: Overexpression of p27 inhibited cell division of miPSCs, and that inhibition was dependent on the expression level of p27. p27 overexpressing miPSCs had pluripotency characteristics but lost stemness earlier than normal miPSCs during embryoid body and teratoma formation. These cellular characteristics led to none or smaller teratoma when the cells were injected into nude mice. Transplantation of both miPSCs and p27 overexpressing miPSCs into the infarcted mouse heart reduced the infarction size and improved left ventricular function. Conclusions: The overexpression of p27 attenuated tumorigenicity by reducing proliferation and earlier loss of stemness of miPSCs. The overexpression of p27 did not affect pluripotency and differentiation characteristics of miPSC. Therefore, regulation of the proliferation rate of miPSCs offers great therapeutic potential for repair of the injured myocardium.

KW - Cell cycle

KW - ES

KW - Embryonic stem cell

KW - Induced pluripotent stem cell

KW - Infarcted heart

KW - Stem cell

KW - Tumor

KW - cdk

KW - iPS

KW - p27

UR - http://www.scopus.com/inward/record.url?scp=84958179656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958179656&partnerID=8YFLogxK

U2 - 10.1186/s13287-016-0286-3

DO - 10.1186/s13287-016-0286-3

M3 - Article

C2 - 26880084

AN - SCOPUS:84958179656

VL - 7

JO - Stem Cell Research and Therapy

JF - Stem Cell Research and Therapy

SN - 1757-6512

IS - 1

M1 - 286

ER -